Mutation analysis of FOXL2 in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome

Chinese Journal of Ophthalmology

Volumn 42, Issue 5, 2006, Pages 409-414

  Qi, Yan Hua ^a   Li, Ying ^b   Lin, Hui ^b   Jia, Hong Yan ^b   Su, Hong ^b   Gu, Jing Zhi ^b   Huang, Shang Zhi ^b   Liu, Ya Ping ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Blepharophimosis; Chromosome mapping; DNA binding proteins; Mutation; Transcription factors

Indexed keywords

DNA FRAGMENT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; UNCLASSIFIED DRUG;

ARTICLE; BLEPHAROPHIMOSIS PTOSIS EPICANTHUS INVERSUS SYNDROME; CHINESE; CHROMOSOME 3Q; CHROMOSOME MAP; CLINICAL ARTICLE; COMPUTER PROGRAM; DNA SEQUENCE; EYE DISEASE; FAMILY; GENE AMPLIFICATION; GENE DUPLICATION; GENE INSERTION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; LINKAGE ANALYSIS; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION;

ASIAN CONTINENTAL ANCESTRY GROUP; BLEPHAROPHIMOSIS; BLEPHAROPTOSIS; CHINA; CHROMOSOMES, HUMAN, PAIR 3; EYELID DISEASES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC LINKAGE; HUMANS; LINKAGE (GENETICS); MALE; MUTATION; PEDIGREE; POLYMORPHISM, GENETIC; SYNDROME;

EID: 33745796792     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zlotogora J, Sagi M, Cohen T. The blepharophimosis, ptosis, epicanthus inversus syndrome: delineation of two types. Am J Hum Genet, 1983,35:1020-1027.
2. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet, 2001,27:159-166.
3. Beysen D, Vandesompele J, Messiaen L, et al. The Human FOXL2 mutation database. Hum Mutat, 2004,24:189-193.
4. De Baere E, Beysen D, Oley C, et al. FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet, 2003,72:478-487.
5. Fryns JP, Stromme P, van den Berghe H. Further evidence for the location of the blepharophimosis syndrome (BPES) at 3q22. 3-q23. Clin Genet, 1993,44:149-151.
6. Amati P, Chomel J, Nivelon. A gene for blepharophimosis-ptosis-epicanthus inversus syndrome maps to chromosome 3q22-q23. Hum Genet, 1995,96:213-215.
7. Small KW, Stalvey M, Fisher L. Blepharophimosis syndrome is linked to chromosome 3q. Hum Mol Genet, 1995, 4:443-448.
8. Harrar Y, Jeffery S, Patton M. Linkage analysis in blepharophimosis-ptosis syndrome confirms localisation to 3q21-24. J Med Genet, 1995,32:774-777.
9. Maw M, Kar B, Biswas J, et al. Linkage of blepharophimosis syndrome in a large Indian pedigree to chromosome 7p. Hum Mol Genet, 1996,5:2049-2054.
10. Warburg M, Bugge M, Brondum-Nielsen K. Cytogenetic findings indicate heterogeneity in patients with blepharophimosis, epicanthus inversus, and developmental delay. J Med Genet, 1995,32:19-24.
11. De Baere E, Dixon MJ, Small KW, et al. Spectrum of FOXL2 gene mutations in Blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet, 2001,10:1591-1600.
12. Cocquet J, Pailhoux E, Jaubert F, et al. Evolution and expression of FOXL2. J Med Genet, 2002,39:916-921.
13. Cocquet J, De Baere E, Gareil M, et al. Structure, evolution and expression of FOXL2 transcription unit. Cytogenet Genome Res, 2003,101:206-211.
14. Loffler KA, Zarkower D, Koopman P. Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocrinology, 2003,144:3237-3243.